Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$35,052,075
-$9,428,863 QoQ
Shares Held
1,455,651
-8.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#211
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Sep 30, 2022CallValue
$25,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $290,206,318 across 12 Drug Manufacturers - General names. PFE ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
411,773 | $78,080,395 | |
| 2 | LLY |
ELI LILLY & Co
|
52,884 | $63,430,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
399,582 | $51,346,286 | |
| 4 | PFE |
Pfizer Inc
This page
|
1,455,651 | $35,052,075 | |
| 5 | JNJ |
Johnson & Johnson
|
78,892 | $20,036,200 | |
| 6 | ABBV |
AbbVie Inc.
|
49,869 | $12,549,032 | |
| 7 | BIIB |
Biogen Inc.
|
56,064 | $12,113,187 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
83,510 | $10,550,651 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,052,075 | 1,455,651 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $44,480,938 | 1,584,079 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $44,804,561 | 1,799,380 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $47,241,498 | 1,854,062 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $48,040,237 | 1,981,858 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $50,329,698 | 1,986,176 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $55,875,096 | 2,106,110 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $65,686,014 | 2,269,731 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $77,626,311 | 2,774,350 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $74,636,843 | 2,689,616 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $75,195,563 | 2,611,864 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $76,320,918 | 2,300,902 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $65,478,566 | 1,785,130 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $55,956,586 | 1,371,485 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $50,527,506 | 986,095 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $25,000 | 50,000 | Call | Sole | 2022-11-09 | |
| 2022-09-30 | $43,223,107 | 987,731 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $51,067,447 | 974,012 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $49,597,367 | 958,033 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $56,631,664 | 959,046 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $52,390,909 | 1,218,110 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $46,987,416 | 1,199,883 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $35,205,160 | 971,713 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $28,613,184 | 777,321 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $30,033,890 | 818,363 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $26,719,425 | 817,107 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $29,439,638 | 901,951 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||